E-LIB Suche - Ergebnisse für: Giordano, Heidi

1

Clinical Pharmacokinetics and Pharmacodynamics of Rucaparib:

Liao, Mingxiang ; Beltman, Jeri ; Giordano, Heidi...
Clinical Pharmacokinetics. 61 (2022) 11 - p. 1477-1493 , 2022

2

Population pharmacokinetics of rucaparib in patients with a..:

Green, Michelle L. ; Ma, Shu Chin ; Goble, Sandra...
Cancer Chemotherapy and Pharmacology. 89 (2022) 5 - p. 671-682 , 2022

Link: https://doi.org/10.1007/..

3

Molecular and clinical determinants of response and resista..:

Swisher, Elizabeth M. ; Kwan, Tanya T. ; Oza, Amit M....
Nature Communications. 12 (2021) 1 - p. , 2021

Link: https://doi.org/10.1038/..

4

Pharmacokinetic Study of Rucaparib in Patients With Advance..:

Shapiro, Geoffrey I. ; Kristeleit, Rebecca S. ; Burris, Howard A....
Clinical Pharmacology in Drug Development. 8 (2018) 1 - p. 107-118 , 2018

Link: https://doi.org/10.1002/..

5

Antitumor activity and safety of the PARP inhibitor rucapar..:

Oza, Amit M. ; Tinker, Anna V. ; Oaknin, Ana...
Gynecologic Oncology. 147 (2017) 2 - p. 267-275 , 2017

Link: https://doi.org/10.1016/..

6

A phase I study of intravenous and oral rucaparib in combin..:

Wilson, Richard H ; Evans, TR Jeffry ; Middleton, Mark R...
British Journal of Cancer. 116 (2017) 7 - p. 884-892 , 2017

Link: https://doi.org/10.1038/..

7

Interallelic Complementation at theDrosophila melanogaster ..:

Ponomareff, Gregory ; Giordano, Heidi ; DeLotto, Yvonne.
Genetics. 159 (2001) 2 - p. 635-645 , 2001

Link: https://doi.org/10.1093/..

8

Clinical Pharmacokinetics and Pharmacodynamics of Rucaparib:

Liao, Mingxiang ; Beltman, Jeri ; Giordano, Heidi...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9652254/. , 2022

Link: http://www.ncbi.nlm.nih...

9

Phase Ib SEASTAR Study: Combining Rucaparib and Sacituzumab..:

Yap, Timothy A ; Hamilton, Erika ; Bauer, Todd...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8865521/. , 2022

Link: http://www.ncbi.nlm.nih...

10

Molecular and clinical determinants of response and resista..:

Swisher, Elizabeth M ; Kwan, Tanya T ; Oza, Amit M...
qt64s245z6. , 2021

Link: https://escholarship.org..

11

Molecular and clinical determinants of response and resista..:

Swisher, Elizabeth M ; Kwan, Tanya T ; Oza, Amit M...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8093258/. , 2021

Link: http://www.ncbi.nlm.nih...

12

Rucaparib Monotherapy in Patients With Pancreatic Cancer an..:

Shroff, Rachna T ; Hendifar, Andrew ; McWilliams, Robert R...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6057747/. , 2018

Link: http://www.ncbi.nlm.nih...

13

Rucaparib Monotherapy in Patients With Pancreatic Cancer an..:

Shroff, Rachna T ; Hendifar, Andrew ; McWilliams, Robert R...
qt0413f8pk. , 2018

Link: https://escholarship.org..

14

Pharmacokinetic Study of Rucaparib in Patients With Advance..:

Shapiro, Geoffrey I ; Kristeleit, Rebecca S ; Burris, Howard A...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6585632/. , 2018

Link: http://www.ncbi.nlm.nih...

15

A phase I study of intravenous and oral rucaparib in combin..:

Wilson, Richard H ; Evans, TR Jeffry ; Middleton, Mark R...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5379148/. , 2017

Link: http://www.ncbi.nlm.nih...